about
MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell lineSurgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomyPractice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus StatementElevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis.Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IBATP-based chemotherapy response assay in primary or recurrent ovarian and peritoneal cancer.MicroRNA-30d and microRNA-181a regulate HOXA11 expression in the uterosacral ligaments and are overexpressed in pelvic organ prolapse.Effect of Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma: A Two-Center Cohort Study and Meta-analysis.Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort StudyPrognostic factors in neuroendocrine cervical carcinoma.MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1Comparison of carboplatin- and cisplatin-based concurrent chemoradiotherapy in locally advanced cervical cancer patients with morbidity risksMakorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology.Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer.The long non-coding RNA HOTAIR increases tumour growth and invasion in cervical cancer by targeting the Notch pathway.Prediction of Recurrence by Preoperative Intratumoral FDG Uptake Heterogeneity in Endometrioid Endometrial Cancer.Endometrial polyp surveillance in premenopausal breast cancer patients using tamoxifen.Identification of Metabolic Biomarkers Using Serial 18F-FDG PET/CT for Prediction of Recurrence in Advanced Epithelial Ovarian CancerTwo-port access laparoscopic surgery in gynecologic oncology.Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer.Prognostic implication of the metastatic lesion-to-ovarian cancer standardised uptake value ratio in advanced serous epithelial ovarian cancer.Prediction of intra-abdominal adhesions using the visceral slide test: A prospective observational study.Prognostic impact of the cancer stem cell-related marker NANOG in ovarian serous carcinoma.Metastasis to the ovaries from transitional cell carcinoma of the bladder and renal pelvis: a report of two cases.Effect of Red Ginseng on Genotoxicity and Health-Related Quality of Life after Adjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer: A Randomized, Double Blind, Placebo-Controlled Trial.Risk factors for negative impacts on sexual activity and function in younger breast cancer survivors.Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer.Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients.Effect of a pH-Balanced Vaginal Gel on Dyspareunia and Sexual Function in Breast Cancer Survivors Who Were Premenopausal at Diagnosis: A Randomized Controlled Trial.Favorable factors for preserving bladder function after nerve-sparing radical hysterectomy: A protocol-based validation study.Super-radical hysterectomy for recurrent cervical cancer.Practice Patterns of Hereditary Ovarian Cancer Management in Korea.Video endoscopic inguinal lymphadenectomy (VEIL) for vulvar cancer.Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancerEffect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancerAsian Society of Gynecologic Oncology International Workshop 2018Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter studyRobotic or laparoscopic sacrohysteropexy versus open sacrohysteropexy for uterus preservation in pelvic organ prolapseImpact of CT-Determined Sarcopenia and Body Composition on Survival Outcome in Patients with Advanced-Stage High-Grade Serous Ovarian CarcinomaLower Extremity Lymphedema in Gynecologic Cancer Patients: Propensity Score Matching Analysis of External Beam Radiation versus Brachytherapy
P50
Q21202160-FB874E09-BCD5-4EDD-87FF-DDF55065E57EQ28075366-A3B52E20-79C1-4390-AAC3-2B205BB5CD76Q29994662-30377C28-B57B-4F76-AD56-F0BD4EFE2C46Q33563950-6D533AE8-FA12-4F8F-8E7B-94D3142D9627Q33760587-B3915DA1-E96E-4694-96A9-D6D0D3CBF59CQ34384450-58075DAE-C1E5-4C19-8661-166DDB79AB49Q35531351-9C5C2236-1572-4DF2-8B93-57CB4E7B097DQ35561162-3CAC5C4D-46CA-423E-BFF2-AA5A6A9FAB9EQ36482461-10BC74C3-BC1A-4749-A6B8-2578E1A3C8D0Q36698509-B12FAEE8-6B36-4B59-A392-41E72BBDE34BQ36962391-DC3AB0C3-8910-4AF6-B681-408F24799431Q37038491-4ADCF112-19D9-4827-8882-8C077F3D91EDQ37204870-62AA39BE-53E7-404A-ABA5-7087A0239F12Q37257019-D034C30B-68C8-4D1C-849C-AE2E902EB5ADQ37536953-677F2590-7C36-4A70-8881-91291B3D77BFQ37627007-EE713710-D6DA-4399-BEA6-9EBEE3867FA5Q37647313-96BBDA0A-056F-41B1-A3C6-A82D3ACF8FCAQ37715868-C5978C62-ED17-4BA8-9E7C-1163E6D16C01Q38108470-FD495E13-A31F-45F2-9EA6-AE9984F1F61AQ38713099-59258925-375E-408E-8D9C-5036BF17E61CQ38737138-7559E0CA-FE04-4409-8086-6D1FEF9A6E66Q38836555-F98CAB07-3513-4BDC-9307-600B28087F4FQ39253952-18D1F8DC-F385-492D-833A-D2EB4C131011Q39909749-A26569FF-52ED-41C2-A47A-C15729AD471FQ41195542-7BB5C3A1-F9E6-49CF-8B9B-6D08C4E29D1FQ41411462-262FBACF-8A95-4FFB-B5F8-83E67104DB8DQ41454606-11C1F42C-1DF7-4B53-9F57-19B6012B61E2Q42942406-7BD9CF5A-55EA-4AA7-A14E-E234CCCCCAB2Q47802021-A858DF79-0394-4E7E-8B32-82F27F67F59DQ48147101-8FE18B3A-BF69-425F-A3F3-1EEA60949A04Q50118330-CDD10EC3-DD7D-429B-B4E0-0AFB3368E84CQ51341370-509505DE-6E5B-45D3-9012-D5A236A54BD1Q52957270-8EEF87EB-019F-49EF-9800-D2BA193B9E97Q59789531-4BFA6622-B45B-4292-8BB3-070B8E05BEFAQ64064000-29A3046E-2E53-4CD2-9E3D-1A6EA8D41FA3Q64231208-98C4D1C5-D87E-45BD-95B9-A7434B4CDF65Q64270829-39F58B15-A364-46B6-947B-5B2FA4882F65Q86581610-4448C9F4-0C99-4624-AE7A-15C9B5CAE586Q89976420-111D9E39-3A25-402E-B2AF-E8EBA1CE24B8Q90419200-C315A27E-3792-4C5B-90CB-504B4A84C06D
P50
description
investigador
@es
researcher
@en
name
Maria Lee
@en
type
label
Maria Lee
@en
prefLabel
Maria Lee
@en
P31
P496
0000-0002-8017-3176